Related resources
Search for item elsewhere
University researcher(s)
Clinical applications of single photon emission tomography in neuromedicine. 1. Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease
Bartenstein P, Grunwald F, Kuwert T, Tatsch K, Sabri O, Benkert O, Fahlbusch R, Grunder G, Herholz, KG, Weiller C.
Nuklearmedizin. 2000;39(7):180-95.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Use our list of Related resources to find this item elsewhere. Alternatively, request a copy from the Library's Document supply service.
Abstract
Arbeitsgemeinschaft Neuronuklearmedizin, Deutschen Gesellschaft fur Nuklearmedizin. Bartenstein@nuklear.klinik.uni-mainz.deSingle photon emission tomography is, because of its availability and the relatively low costs, the functional imaging modality currently most widely used for clinical applications in the brain. Beside the application of radiopharmaceuticals for the assessment of regional cerebral blood flow there is an increasing clinical use of more selective SPECT-radiopharmaceuticals, like amino acid analogs or receptor ligands. This article gives in his first part a critical review of the clinical applications of SPECT in neuro-oncology, epilepsy, basal ganglia disorders and cerebrovascular disease.PMID: 11127047 [PubMed - indexed for MEDLINE]